ORAL ANTIVIRUS FOR COVID-19
The coronavirus disease 2019 (COVID-19) pandemic continues to grow. Protective vaccines have been developed within unprecedented timelines, but current supplies are too low to cover worldwide demand in the coming months. Moreover, a significant number of people are either unable, due to pre-existing medical conditions, or unwilling to be vaccinated, and global access challenges remain.
Read more
Most Commented